Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Dec;36(12):906–913.

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?

L Lodder 1, P Frets 1, R Trijsburg 1, E Meijers-Heijboer 1, J Klijn 1, H Duivenvoorden 1, A Tibben 1, A Wagner 1, C A van der Meer 1, P Devilee 1, C Cornelisse 1, M Niermeijer 1, m other 1
PMCID: PMC1734277  PMID: 10593998

Abstract

Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 and BRCA2 genes in 1994-1995. Healthy female mutation carriers have a high lifetime risk for breast cancer (56-87%) or ovarian cancer (10-60%) and may opt for intensive breast and ovary surveillance or prophylactic surgery (mastectomy/oophorectomy).
We studied general and cancer related distress in 85 healthy women with a 25% or 50% risk of being carrier of a BRCA1/BRCA2 gene mutation and 66 partners in the six to eight week period between genetic counselling/blood sampling and disclosure of the test result. Questionnaire and interview data are analysed. Associations are explored between levels of distress and (1) expected consequences of being identified as a mutation carrier, (2) personality traits, (3) sociodemographic variables, and (4) experiences related to HBOC.
Mean pre-test anxiety and depression levels in women at risk of being a carrier and partners were similar to those of a normal Dutch population. In about 25% of those at risk of being a carrier and 10% of the partners, increased to high levels of general and cancer related distress were found. Increased levels of distress were reported by women who (1) anticipated an increase in problems after an unfavourable test outcome, (2) considered prophylactic mastectomy if found to be mutation carrier, (3) had an unoptimistic personality, (4) tended to suppress their emotions, (5) were younger than 40 years, and (6) were more familiar with the serious consequences of HBOC. Recently obtained awareness of the genetic nature of cancer in the family was not predictive of distress.
The majority of the women and their partners experienced a relatively calm period before the disclosure of the test result and seemed to postpone distressing thoughts until the week of disclosure of the result. The low distress levels may partly be explained by the use of strategies to minimise the emotional impact of a possibly unfavourable test outcome. However, a minority reported feeling very distressed. Several factors were found to be predictive for increased distress levels.


Keywords: genetic testing; cancer; BRCA1/BRCA2; psychological distress

Full Text

The Full Text of this article is available as a PDF (96.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackwood M. A., Weber B. L. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol. 1998 May;16(5):1969–1977. doi: 10.1200/JCO.1998.16.5.1969. [DOI] [PubMed] [Google Scholar]
  2. Bleiker E. M., van der Ploeg H. M., Hendriks J. H., Adèr H. J. Personality factors and breast cancer development: a prospective longitudinal study. J Natl Cancer Inst. 1996 Oct 16;88(20):1478–1482. doi: 10.1093/jnci/88.20.1478. [DOI] [PubMed] [Google Scholar]
  3. Bleiker E. M., van der Ploeg H. M., Hendriks J. H., Leer J. W., Kleijn W. C. Rationality, emotional expression and control: psychometric characteristics of a questionnaire for research in psycho-oncology. J Psychosom Res. 1993 Dec;37(8):861–872. doi: 10.1016/0022-3999(93)90175-f. [DOI] [PubMed] [Google Scholar]
  4. Channer K. S., Papouchado M., James M. A., Rees J. R. Anxiety and depression in patients with chest pain referred for exercise testing. Lancet. 1985 Oct 12;2(8459):820–823. doi: 10.1016/s0140-6736(85)90805-0. [DOI] [PubMed] [Google Scholar]
  5. Croyle R. T., Smith K. R., Botkin J. R., Baty B., Nash J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol. 1997 Jan;16(1):63–72. doi: 10.1037//0278-6133.16.1.63. [DOI] [PubMed] [Google Scholar]
  6. Decruyenaere M., Evers-Kiebooms G., Boogaerts A., Cassiman J. J., Cloostermans T., Demyttenaere K., Dom R., Fryns J. P., Van den Berghe H. Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. J Med Genet. 1996 Sep;33(9):737–743. doi: 10.1136/jmg.33.9.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Derogatis L. R., Rickels K., Rock A. F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976 Mar;128:280–289. doi: 10.1192/bjp.128.3.280. [DOI] [PubMed] [Google Scholar]
  8. DudokdeWit A. C., Tibben A., Duivenvoorden H. J., Frets P. G., Zoeteweij M. W., Losekoot M., van Haeringen A., Niermeijer M. F., Passchier J. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup. J Med Genet. 1997 May;34(5):382–390. doi: 10.1136/jmg.34.5.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DudokdeWit A. C., Tibben A., Frets P. G., Meijers-Heijboer E. J., Devilee P., Klijn J. G., Oosterwijk J. C., Niermeijer M. F. BRCA1 in the family: a case description of the psychological implications. Am J Med Genet. 1997 Jul 11;71(1):63–71. doi: 10.1002/(sici)1096-8628(19970711)71:1<63::aid-ajmg12>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Duits A. A., Duivenvoorden H. J., Boeke S., Taams M. A., Mochtar B., Krauss X. H., Passchier J., Erdman R. A. The course of anxiety and depression in patients undergoing coronary artery bypass graft surgery. J Psychosom Res. 1998 Aug;45(2):127–138. doi: 10.1016/s0022-3999(97)00307-3. [DOI] [PubMed] [Google Scholar]
  11. Ford D., Easton D. F., Bishop D. T., Narod S. A., Goldgar D. E. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 1994 Mar 19;343(8899):692–695. doi: 10.1016/s0140-6736(94)91578-4. [DOI] [PubMed] [Google Scholar]
  12. Gibbons R. D., Hedeker D., Elkin I., Waternaux C., Kraemer H. C., Greenhouse J. B., Shea M. T., Imber S. D., Sotsky S. M., Watkins J. T. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993 Sep;50(9):739–750. doi: 10.1001/archpsyc.1993.01820210073009. [DOI] [PubMed] [Google Scholar]
  13. Hopwood P. Psychological issues in cancer genetics: current research and future priorities. Patient Educ Couns. 1997 Sep-Oct;32(1-2):19–31. doi: 10.1016/s0738-3991(97)00060-8. [DOI] [PubMed] [Google Scholar]
  14. Horowitz M., Wilner N., Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979 May;41(3):209–218. doi: 10.1097/00006842-197905000-00004. [DOI] [PubMed] [Google Scholar]
  15. Kash K. M., Holland J. C., Halper M. S., Miller D. G. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst. 1992 Jan 1;84(1):24–30. doi: 10.1093/jnci/84.1.24. [DOI] [PubMed] [Google Scholar]
  16. Lerman C., Kash K., Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;(16):171–176. [PubMed] [Google Scholar]
  17. Lerman C., Schwartz M. D., Lin T. H., Hughes C., Narod S., Lynch H. T. The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol. 1997 Jun;65(3):414–420. doi: 10.1037//0022-006x.65.3.414. [DOI] [PubMed] [Google Scholar]
  18. Lerman C., Schwartz M. D., Miller S. M., Daly M., Sands C., Rimer B. K. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol. 1996 Mar;15(2):75–83. doi: 10.1037//0278-6133.15.2.75. [DOI] [PubMed] [Google Scholar]
  19. Lerman C., Seay J., Balshem A., Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995 Jul 3;57(3):385–392. doi: 10.1002/ajmg.1320570304. [DOI] [PubMed] [Google Scholar]
  20. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994 Oct 7;266(5182):66–71. doi: 10.1126/science.7545954. [DOI] [PubMed] [Google Scholar]
  21. Scheier M. F., Carver C. S. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol. 1985;4(3):219–247. doi: 10.1037//0278-6133.4.3.219. [DOI] [PubMed] [Google Scholar]
  22. Spinhoven P., Ormel J., Sloekers P. P., Kempen G. I., Speckens A. E., Van Hemert A. M. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997 Mar;27(2):363–370. doi: 10.1017/s0033291796004382. [DOI] [PubMed] [Google Scholar]
  23. Tibben A., Frets P. G., van de Kamp J. J., Niermeijer M. F., Vegter-van der Vlis M., Roos R. A., van Ommen G. J., Duivenvoorden H. J., Verhage F. Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet. 1993 May 1;48(1):10–16. doi: 10.1002/ajmg.1320480105. [DOI] [PubMed] [Google Scholar]
  24. Tibben A., Vegter-vd Vlis M., Skraastad M. I., Leeuwen-Cornelisse I. S., Frets P. G., vd Kamp J. J., Niermeijer M. F., von Ommen G. J., Roos R. A., Rooijmans H. G. Presymptomatic DNA-testing for Huntington disease in The Netherlands. Birth Defects Orig Artic Ser. 1992;28(1):127–131. [PubMed] [Google Scholar]
  25. Watson M., Pettingale K. W., Greer S. Emotional control and autonomic arousal in breast cancer patients. J Psychosom Res. 1984;28(6):467–474. doi: 10.1016/0022-3999(84)90080-1. [DOI] [PubMed] [Google Scholar]
  26. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21;378(6559):789–792. doi: 10.1038/378789a0. [DOI] [PubMed] [Google Scholar]
  27. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES